Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
174.6 USD | +3.20% |
|
+4.20% | +13.05% |
03:54pm | TD Cowen Adjusts Price Target on AbbVie to $195 From $180 | MT |
12/07 | AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.05% | 299B | |
+56.34% | 848B | |
+33.15% | 627B | |
-0.01% | 363B | |
+15.08% | 318B | |
+14.83% | 243B | |
+16.81% | 225B | |
+16.48% | 179B | |
+4.01% | 167B | |
+2.71% | 125B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Transcript : AbbVie Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-08-2013 03